文献速递瓣膜外科

快速部署主动脉瓣置换术后永久起搏器植入

Permanent Pacemaker Implantation After Rapid Deployment Aortic Valve Replacement.
PubMed 文献 · Ann Thorac Surg · 2018-04-26

基于TRANSFORM试验708例无既往起搏器患者,快速部署主动脉瓣置换术后30天永久起搏器植入发生率为13.6%,其中10.9%因房室传导阻滞。基线右束支传导阻滞、女性、较大瓣膜尺寸是独立预测因素,且中心间存在两倍以上差异。

要点

  • 快速部署主动脉瓣置换术后30天永久起搏器植入率为13.6%,房室传导阻滞占10.9%。
  • 无基线传导异常者30天起搏器植入率为8%,房室传导阻滞为5%。
  • 基线右束支传导阻滞OR 7.35、女性OR 2.62、较大瓣膜尺寸OR 1.20为独立预测因素。

核心结论

  • 快速部署主动脉瓣置换术后永久起搏器植入相关患者因素为右束支传导阻滞、房室传导阻滞、女性和较大瓣膜尺寸。
  • 中心层面效应与起搏器植入强烈相关,可能反映术后药物管理或起搏器植入时机等实践模式差异。

研究设计与样本

  • 多中心TRANSFORM试验分析,纳入29个中心708例无既往起搏器、接受快速部署主动脉瓣置换术(伴或不伴冠状动脉旁路移植术)的患者。
  • 记录内在传导状态及1年内永久起搏器植入发生率,起搏器植入指征经专家审阅源文件分类,多变量分析识别相关特征。

主要发现

  • 术后30天永久起搏器植入率(PPI30)为13.6%,其中10.9%因房室传导阻滞。
  • 708例中423例(59.7%)无基线传导异常,其全因PPI30为8%,房室传导阻滞为5%。
  • 出院前植入起搏器的中位时间为5天,22%在48小时内植入。
  • PPI30独立预测因素:基线右束支传导阻滞(OR 7.35,p < 0.0001)、女性(OR 2.62,p = 0.004)、较大瓣膜尺寸(OR 1.20,p = 0.016)、房室传导阻滞(OR 1.80,p = 0.062)。
  • 亚组分析显示最大入组中心间PPI30差异超过两倍。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Expandable, rapid deployment aortic valves may interfere with the cardiac conduction system, which can lead to permanent pacemaker implantation (PPI). We sought to characterize PPI after rapid deployment aortic valve replacement with the Edwards Intuity valve system (Edwards Lifesciences, Irvine, CA) and investigate associated factors. METHODS: We analyzed 708 patients from 29 centers in the Multicenter Experience With Rapid Deployment Edwards Intuity Valve System for Aortic Valve Replacement (TRANSFORM) trial undergoing rapid deployment aortic valve replacement with or without coronary artery bypass graft surgery without preexisting pacemakers. Intrinsic conduction status was recorded as well as PPI incidence through 1 year. The PPI indications were categorized based on expert review of patient PPI source documents. Multivariate analysis was conducted to identify characteristics associated with PPI. RESULTS: After rapid deployment aortic valve replacement, the PPI incidence through 30 days (PPI30) was 13.6%, with 10.9% due to atrioventricular block. In the 423 of 708 patients (59.7%) without any baseline conduction abnormalities, all-cause PPI30 was 8%, 5% for atrioventricular block. For PPIs inserted before discharge, the median time to PPI was 5 days, with 22% placed within 48 hours. Independent predictors of PPI30 were baseline right bundle branch block (odds ratio 7.35, p < 0.0001), female gender (2.62, p = 0.004), larger valve size (1.20, p = 0.016), and atrioventricular block (1.80, p = 0.062). Subset analysis revealed a greater than twofold difference in PPI30 among the largest enrolling centers. CONCLUSIONS: Patient factors associated with PPI after rapid deployment aortic valve replacement were right bundle branch block, atrioventricular block, female gender, and larger valve size. Interestingly, a strong center-level effect was associated with PPI. This effect may reflect differences in practice patterns, such as postoperative drug management or timing to PPI. These findings provide a deeper understanding of PPI after rapid deployment aortic valve replacement and help guide clinical practice and patient management.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Romano MA, Koeckert M, Mumtaz MA, et al. Permanent Pacemaker Implantation After Rapid Deployment Aortic Valve Replacement. Ann Thorac Surg. 2018. PMID: 29705366. doi:10.1016/j.athoracsur.2018.03.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。